Version 1
: Received: 25 October 2022 / Approved: 27 October 2022 / Online: 27 October 2022 (07:56:25 CEST)
How to cite:
Lambert, N.; Vinke, E.; Barrett, T.; Meglin, A.; Shou, J.; Welch, K. Application of Umbilical Cord Tissue Allografts in Reduction Mammoplasty Wound: A Case Study. Preprints2022, 2022100422. https://doi.org/10.20944/preprints202210.0422.v1
Lambert, N.; Vinke, E.; Barrett, T.; Meglin, A.; Shou, J.; Welch, K. Application of Umbilical Cord Tissue Allografts in Reduction Mammoplasty Wound: A Case Study. Preprints 2022, 2022100422. https://doi.org/10.20944/preprints202210.0422.v1
Lambert, N.; Vinke, E.; Barrett, T.; Meglin, A.; Shou, J.; Welch, K. Application of Umbilical Cord Tissue Allografts in Reduction Mammoplasty Wound: A Case Study. Preprints2022, 2022100422. https://doi.org/10.20944/preprints202210.0422.v1
APA Style
Lambert, N., Vinke, E., Barrett, T., Meglin, A., Shou, J., & Welch, K. (2022). <span data-contrast="none">Application of Umbilical Cord Tissue Allografts in Reduction Mammoplasty Wound: A Case Study<span data-ccp-props="{">. Preprints. https://doi.org/10.20944/preprints202210.0422.v1
Chicago/Turabian Style
Lambert, N., John Shou and Kevin Welch. 2022 "<span data-contrast="none">Application of Umbilical Cord Tissue Allografts in Reduction Mammoplasty Wound: A Case Study<span data-ccp-props="{">" Preprints. https://doi.org/10.20944/preprints202210.0422.v1
Abstract
Nearly 15 million patients undergo cosmetic surgery in the United States each year, with breast augmentations such as implants, lifts, or reductions being some of the most common procedures. The most common complications of these procedures are scarring and infection at the incision site, which often necessitates expensive corrective surgery. After significant weight loss, the patient in this study underwent an elective lower body lift in conjunction with a breast reduction and nipple-areolar transplant. An autologous skin graft was used at the transplant donor site. The skin graft unfortunately necrosed, warranting the need for rapid wound closure to avoid further pain and infection. The patient was treated for eight weeks with conservative measures. After eight weeks of failed attempts to close her wound, she was referred for specialist care. Upon initial examination, the donor site wound measured 3.5 cm x 3.5 cm with no sign of epithelialization. The patient received a single dose of Wharton’s jelly flowable perinatal tissue allograft and five hyperbaric oxygen therapy treatments over seven weeks. Upon inspection at the final examination, the wound was closed entirely with 100% epithelialization overlying granulation tissue. This case study demonstrates a precedent for the application of Wharton’s jelly flowable allografts in complicated cosmetic post-surgical wounds. Future efforts will be directed at applying Wharton’s jelly allografts on a preventative basis. Preventative applications could be in stage 2 pressure sores or intra-operatively to decrease potential patient suffering, prevent emotional distress, and reduce unnecessary healthcare expenses.
Breast Augmentation; Reduction Mammoplasty; non-healing surgical wound; Wharton's jelly allograft
Subject
Biology and Life Sciences, Biology and Biotechnology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
